oxygen-sensing PHD1 antisense oligonucleotides (Ionis/University of Colorado)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameoxygen-sensing PHD1 antisense oligonucleotides (Ionis/University of Colorado)
Drug Alias Nameoxygen-sensing prolyl hydroxylases 1 antisense oligonucleotides (Isis Pharmaceuticals/University of Colorad)oxygen-sensing prolyl hydroxylases 1 antisense oligonucleotides (Ionis/University of Colorado)PHD1 ASO-1PHD1 ASO-2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProlyl hydroxylase domain-containing protein 1 inhibitorsAntisense oligonucleotide inhibitors
TargetsProlyl hydroxylase domain-containing protein 1
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Colorado SystemIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A